(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

ESSERRE

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

ESSERRE

ST13

US500000079365506

Classe

1, 5

Pedido

79365506

Registro

7435507

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

34

Atualização mais recente

07/08/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

1, 5

Data de depósito

02/12/2022

Data de registro

09/07/2024

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

09/07/2024

Última transação

07/08/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

98

Localização do titular

IT

Examinador

ATTANG, UDEME U

Unidade examinadora

M60

Localização atual

FILE REPOSITORY (FRANCONIA)

Titulares e representantes

Titulares

ESSERRE PHARMA S.r.l.
ESSERRE PHARMA S.r.l.

Representantes

Larry H. Tronco Holland & Hart, LLP

Classificação técnica

Classes Nice

Classe 1Classe 5

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Chemical and organic compositions in the nature of fruit extracts and nutraceuticals for the manufacture of food and drink; Chemical substanceschemical materials and preparationsnatural elements being fruit extracts and nutraceuticals for use in the manufacture of food supplements and cosmetics; Chemical compounds and materials for use in sciencereagents for scientific use; Chemical compounds and materials being additives for use in the manufacture of cosmetics; Chemicals for use in the manufacture of pharmaceuticals; Plant extracts for use in the manufacture of pharmaceutical products; Vitamins for use in the manufacture of pharmaceutical products; chemicals for use in the manufacture of food supplements; Plant extracts for use in the manufacture of food supplements; plant extracts for use in the food industryplant extracts in the manufacture of foods; plant extracts for use in the manufacture of cosmetics; Botanical extractsother than essential oilsfor use in the manufacture of cosmetics

Classe 5

Pharmaceutical and natural medicines for the treatment of cardiometabolic and cardiovascular risk factorsvascular diseasegastrointestinal disordersinflammation and edema of tissuesflucough and coldfatiguemalnutritionsarcopeniaimmune system deficienciesallergyhypovitaminosiscognitive impairmentmental disorderssleep disordersmusculoskeletal achesosteoarticular disordersskin disordersnails and hair disorderselectrolyte imbalancesanemiamineral deficiencyheadacheurogenital disordersgynecological disordersinfertilitydental disordershepatobiliary disorderspancreatic disordersliver diseaseobesitydiabeteseye diseaserespiratory system diseaseulcerstrauma; Food supplements and dietary preparations being dietary supplements for the treatment of cardiometabolic and cardiovascular risk factorsvascular diseasegastrointestinal disordersinflammation and edema of tissuesflucough and coldfatiguemalnutritionsarcopeniaimmune system deficienciesallergyhypovitaminosiscognitive impairmentmental disorderssleep disordersmusculoskeletal achesosteoarticular disordersskin disordersnails and hair disorderselectrolyte imbalancesanemiamineral deficiencyheadacheurogenital disordersgynecological disordersinfertilitydental disordershepatobiliary disorderspancreatic disordersliver diseaseobesitydiabeteseye diseaserespiratory system diseaseulcerstrauma; Pharmaceutical productsskin lotions and dermatological preparations

Publicações

Histórico de despachos e eventos da marca no USPTO.

34 publicações encontradas

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

06/08/2026

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

05/01/2025

FICS

FINAL DISPOSITION NOTICE SENT TO IB

18/12/2024

FIMP

FINAL DISPOSITION PROCESSED

18/12/2024

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

09/10/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

09/07/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

09/07/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/05/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

25/04/2024

GPNX

NOTIFICATION PROCESSED BY IB

23/04/2024

PUBO

PUBLISHED FOR OPPOSITION

23/04/2024

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

03/04/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/04/2024

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

03/04/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

15/03/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

15/03/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

15/03/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

15/03/2024

CNEA

EXAMINERS AMENDMENT -WRITTEN

15/03/2024

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

09/03/2024

GNFR

FINAL REFUSAL E-MAILED

09/03/2024

CNFR

FINAL REFUSAL WRITTEN

09/03/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

24/01/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

23/01/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

23/01/2024

RFNT

REFUSAL PROCESSED BY IB

25/10/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

03/10/2023

RFRR

REFUSAL PROCESSED BY MPU

03/10/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

21/09/2023

CNRT

NON-FINAL ACTION WRITTEN

20/09/2023

DOCK

ASSIGNED TO EXAMINER

12/09/2023

MAFR

APPLICATION FILING RECEIPT MAILED

24/03/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

20/03/2023

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

16/03/2023

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace ESSERRE ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.